Digestive Health

News Watch

Stomach pain, flatulence, bloating, discomfort. These are just some of the symptoms of Irritable Bowel Syndrome (IBS), a chronic condition affecting more than 10% of the population with highest impact in women. Treatment cannot cure the condition, only alleviate the symptoms. Its origin is unknown, although increasingly more researchers suspect that imbalances in the gut microbiota may play a major…

GMFH Editing Team
GMFH Editing Team

Stomach pain, flatulence, bloating, discomfort. These are just some of the symptoms of Irritable Bowel Syndrome (IBS), a chronic condition affecting more than 10% of the population with highest impact in women. Treatment cannot cure the condition, only alleviate the symptoms. Its origin is unknown, although increasingly more researchers suspect that imbalances in the gut microbiota may play a major…

GMFH Editing Team
GMFH Editing Team

Thirty-three percent of people have a gene that predisposes them to celiac disease (CD), while only two to five percent of the population will receive a diagnosis of the condition. Elena Verdú, Associate Professor and researcher at McMaster University in Canada, wants to know why the unlucky minority end up with the disease. "We know that genes are necessary, but…

GMFH Editing Team
GMFH Editing Team

Thirty-three percent of people have a gene that predisposes them to celiac disease (CD), while only two to five percent of the population will receive a diagnosis of the condition. Elena Verdú, Associate Professor and researcher at McMaster University in Canada, wants to know why the unlucky minority end up with the disease. "We know that genes are necessary, but…

GMFH Editing Team
GMFH Editing Team

In inflammatory bowel disease (IBD), a set of conditions that includes Crohn’s disease and ulcerative colitis (UC), parts of the digestive tract become chronically inflamed. 'Debilitating' doesn't begin to describe IBD at its most intense: during a disease flare, someone who normally leads a busy and active life may have to put everything on hold to stay at home, close…

GMFH Editing Team
GMFH Editing Team

In inflammatory bowel disease (IBD), a set of conditions that includes Crohn’s disease and ulcerative colitis (UC), parts of the digestive tract become chronically inflamed. 'Debilitating' doesn't begin to describe IBD at its most intense: during a disease flare, someone who normally leads a busy and active life may have to put everything on hold to stay at home, close…

GMFH Editing Team
GMFH Editing Team

Butterflies in your stomach before a big presentation is a familiar experience, but surprisingly, scientists don't yet know exactly how this happens. The gut-brain axis – the brain's influence on the gastrointestinal tract and the other way around – is now a subject of keen scientific interest. A recent review, published in Neuropsychiatric Disease and Treatment, covered what we know…

GMFH Editing Team
GMFH Editing Team

Butterflies in your stomach before a big presentation is a familiar experience, but surprisingly, scientists don't yet know exactly how this happens. The gut-brain axis – the brain's influence on the gastrointestinal tract and the other way around – is now a subject of keen scientific interest. A recent review, published in Neuropsychiatric Disease and Treatment, covered what we know…

GMFH Editing Team
GMFH Editing Team

Digestion is extraordinarily complex, and there is a long list of ways it can go wrong. From constipation to bloating, digestive disorders can cause significant distress for infants and children as they develop. Fortunately, with emerging research on the microbiota, doctors, dietitians, and other healthcare professionals have a growing list of science-based strategies to use in addressing these problems. Healthcare…

GMFH Editing Team
GMFH Editing Team

Digestion is extraordinarily complex, and there is a long list of ways it can go wrong. From constipation to bloating, digestive disorders can cause significant distress for infants and children as they develop. Fortunately, with emerging research on the microbiota, doctors, dietitians, and other healthcare professionals have a growing list of science-based strategies to use in addressing these problems. Healthcare…

GMFH Editing Team
GMFH Editing Team

Research & Practice

Crohn’s disease (CD) is a relapsing inflammatory bowel disease that results from a complex interplay between host genetic factors and endogenous microbial communities. Host factors and environmental factors may have effects on the microbiota and possibly initiate inflammation, but then gut dysbiosis may play a role in maintaining this cycle of inflammation. While the vast majority of studies have focused…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Crohn’s disease (CD) is a relapsing inflammatory bowel disease that results from a complex interplay between host genetic factors and endogenous microbial communities. Host factors and environmental factors may have effects on the microbiota and possibly initiate inflammation, but then gut dysbiosis may play a role in maintaining this cycle of inflammation. While the vast majority of studies have focused…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Crohn’s disease (CD) is a chronic inflammatory condition of diverse aetiology in which host genetics and the gut microbiome may interact to regulate susceptibility. People with CD tend to have higher numbers of a type of gut bacteria known as adherent-invasive Escherichia coli (AIEC) in their guts. Besides this, acute infectious gastroenteritis caused by Salmonella or other enteric pathogens, increase…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Crohn’s disease (CD) is a chronic inflammatory condition of diverse aetiology in which host genetics and the gut microbiome may interact to regulate susceptibility. People with CD tend to have higher numbers of a type of gut bacteria known as adherent-invasive Escherichia coli (AIEC) in their guts. Besides this, acute infectious gastroenteritis caused by Salmonella or other enteric pathogens, increase…

Paul Enck
Prof. Dr. Paul Enck, Director of Research, Dept. of Psychosomatic Medicine and Psychotherapy, University Hospital Tübingen, Germany. His main interests are gut functions in health and disease, including functional and inflammatory bowel disorders, the role of the gut microbiota, regulation of eating and food intake and its disorders, of nausea, vomiting and motion sickness, and the psychophysiology and neurobiology of the placebo response, with specific emphasis on age and gender contributions. He has published more than 170 original data paper in scientific, peer-reviewed journals, and more than 250 book chapters and review articles. He is board member/treasurer of the European Society of Neurogastroenterology and Motility and of the German Society of Neurogastroenterology and Motility, and has served as reviewer for many international journals and grant agencies.

Recent research has shown that the effects of pharmacological treatments need to be disentangled from the effects of specific diseases on the human microbiota, as drug therapy effects may be a potential confound in human microbiome studies. However, to what extent drug treatment effectiveness is related to changes in gut microbiota composition and functionality is poorly studied. A recent study,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Recent research has shown that the effects of pharmacological treatments need to be disentangled from the effects of specific diseases on the human microbiota, as drug therapy effects may be a potential confound in human microbiome studies. However, to what extent drug treatment effectiveness is related to changes in gut microbiota composition and functionality is poorly studied. A recent study,…

Andreu Prados
Andreu Prados holds a Bachelor of Science Degree in Pharmacy & Human Nutrition and Dietetics. Science writer specialised in gut microbiota and probiotics, working also as lecturer and consultant in nutrition and healthcare. Follow Andreu on Twitter @andreuprados

Gut Microbiota for Health’s gastroenterology e-learning course on the gut microbiota now has a new home! This 1-hour video course, which covers evidence on the role of the gut microbiota in normal gut function and in gastrointestinal disease, will now join the collection of material for continuing medical education available through United European Gastroenterology (UEG). This clinically-oriented summary of gut…

GMFH Editing Team
GMFH Editing Team

Gut Microbiota for Health’s gastroenterology e-learning course on the gut microbiota now has a new home! This 1-hour video course, which covers evidence on the role of the gut microbiota in normal gut function and in gastrointestinal disease, will now join the collection of material for continuing medical education available through United European Gastroenterology (UEG). This clinically-oriented summary of gut…

GMFH Editing Team
GMFH Editing Team

The intestinal microbiota appears to be a key determinant of health and disease. Indeed, microbiota differences are associated with a number of inflammatory diseases, including inflammatory bowel disease (IBD). However, the method by which alterations in the microbiota composition (influenced by genetics, the environment, and diet) contribute to IBD pathogenesis is not well understood. In a recently published paper in…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.

The intestinal microbiota appears to be a key determinant of health and disease. Indeed, microbiota differences are associated with a number of inflammatory diseases, including inflammatory bowel disease (IBD). However, the method by which alterations in the microbiota composition (influenced by genetics, the environment, and diet) contribute to IBD pathogenesis is not well understood. In a recently published paper in…

Heather Galipeau
Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during which she found that the small intestinal microbial background influences the degree of immuno-pathology triggered by dietary antigens, such as gluten.